CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 81 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,266,331 | +234.1% | 108,326 | +8.1% | 0.03% | -18.9% |
| Q3 2018 | $379,000 | +44.1% | 100,181 | +19.0% | 0.04% | +60.9% |
| Q2 2018 | $263,000 | -10.5% | 84,181 | -31.6% | 0.02% | -34.3% |
| Q1 2018 | $294,000 | +54.7% | 123,000 | +78.3% | 0.04% | -12.5% |
| Q2 2017 | $190,000 | -28.3% | 68,970 | -49.2% | 0.04% | -18.4% |
| Q1 2017 | $265,000 | +173.2% | 135,872 | +242.3% | 0.05% | +14.0% |
| Q4 2015 | $97,000 | -49.2% | 39,695 | -37.7% | 0.04% | -52.7% |
| Q3 2015 | $191,000 | – | 63,667 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |